Share this post:

During the session, titled “Access and stewardship plans during antibiotic research and development,” the Access to Medicine Foundation, CARB-X and GARDP will share how they guide, support and partner with pharmaceutical companies to achieve access and stewardship goals. Mirfin Mpundu, Executive Director of the Ecumenical Pharmaceutical Network and Head of ReAct Africa, and Sabiha Yusuf Essack, South African Research Chair in Antibiotic Resistance and One Health at the University of KwaZulu-Natal, will act as discussants. Jason Gale, Senior Editor at Bloomberg, will moderate an open conversation related to the role of different sectors in improving access and stewardship strategies during the R&D process.

Effectively addressing drug-resistant infections requires concerted efforts across sectors, including governments, industry and civil society. For example, research funders, product development partnerships (PDPs) and pharmaceutical companies play different but fundamental roles to ensure that new antibiotics will be accessible to the patients who need them as well as that they will be used responsibly. By considering access-to-medicine barriers and stewardship needs early on in the antibiotics research and development (R&D) process, these actors can ensure that the most appropriate product features are selected. This prompt selection also allows for sufficient time to integrate these considerations into supply, registration and pricing strategies.

Damiano de Felice, Director of Strategy at the Access to Medicine Foundation, will also participate in the official programme of the Second Cal to Action event, which is co-hosted by the governments of Ghana and Thailand, the United Nations Foundation and the Wellcome Trust, and is organised in partnership with the Inter-Agency Coordination Group (IACG) on Antimicrobial Resistance (AMR). Damiano will first join a panel titled “What is the role of private sector and civil society organisations in supporting stewardship and access to quality antimicrobials” and then participate in the closing plenary session on “How could and should private sector and civil society organisations be doing more to support governments in the fight against AMR.”

You can live stream these sessions from the Wellcome AMR Twitter page on 20 November from 14:50 WAT. Participants of the Call to Action event will include representatives from civil society, national governments and agencies, the private sector, and global philanthropies. They will focus on how to address the most critical gaps in tackling the spread and development of drug-resistant infections.